219 related articles for article (PubMed ID: 16271102)
21. Common presence of non-transferrin-bound iron among patients with type 2 diabetes.
Lee DH; Liu DY; Jacobs DR; Shin HR; Song K; Lee IK; Kim B; Hider RC
Diabetes Care; 2006 May; 29(5):1090-5. PubMed ID: 16644642
[TBL] [Abstract][Full Text] [Related]
22. Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform.
Jacobs EM; Hendriks JC; van Tits BL; Evans PJ; Breuer W; Liu DY; Jansen EH; Jauhiainen K; Sturm B; Porter JB; Scheiber-Mojdehkar B; von Bonsdorff L; Cabantchik ZI; Hider RC; Swinkels DW
Anal Biochem; 2005 Jun; 341(2):241-50. PubMed ID: 15907869
[TBL] [Abstract][Full Text] [Related]
23. Effect of repeated apotransferrin administrations on serum iron parameters in patients undergoing myeloablative conditioning and allogeneic stem cell transplantation.
Parkkinen J; Sahlstedt L; von Bonsdorff L; Salo H; Ebeling F; Ruutu T
Br J Haematol; 2006 Oct; 135(2):228-34. PubMed ID: 16925790
[TBL] [Abstract][Full Text] [Related]
24. Lack of non-transferrin-bound iron in heart transplant recipients.
Przybylowski P; Malyszko J; Levin-Iaina N; Malyszko JS
Transplant Proc; 2011 Oct; 43(8):3068-70. PubMed ID: 21996227
[TBL] [Abstract][Full Text] [Related]
25. Bleomycin-detectable iron assay for non-transferrin-bound iron in hematologic malignancies.
von Bonsdorff L; Lindeberg E; Sahlstedt L; Lehto J; Parkkinen J
Clin Chem; 2002 Feb; 48(2):307-14. PubMed ID: 11805012
[TBL] [Abstract][Full Text] [Related]
26. Influence of non-enzymatic post-translation modifications on the ability of human serum albumin to bind iron. Implications for non-transferrin-bound iron speciation.
Silva AM; Hider RC
Biochim Biophys Acta; 2009 Oct; 1794(10):1449-58. PubMed ID: 19505594
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of bacterial inactivation in prestorage pooled, leukoreduced, whole blood-derived platelet concentrates suspended in plasma prepared with photochemical treatment.
Brecher ME; Hay S; Corash L; Hsu J; Lin L
Transfusion; 2007 Oct; 47(10):1896-901. PubMed ID: 17880617
[TBL] [Abstract][Full Text] [Related]
28. Non-transferrin bound iron measurement is influenced by chelator concentration.
Kolb AM; Smit NP; Lentz-Ljuboje R; Osanto S; van Pelt J
Anal Biochem; 2009 Feb; 385(1):13-9. PubMed ID: 19026979
[TBL] [Abstract][Full Text] [Related]
29. Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron.
von Bonsdorff L; Sahlstedt L; Ebeling F; Ruutu T; Parkkinen J
FEMS Immunol Med Microbiol; 2003 Jun; 37(1):45-51. PubMed ID: 12770759
[TBL] [Abstract][Full Text] [Related]
30. Increased non-transferrin bound iron in plasma-depleted SAG-M red blood cell units.
Marwah SS; Blann A; Harrison P; Lumley MA; Wright J; McDowell J; Phillips JD; Rea C; Bareford D
Vox Sang; 2002 Apr; 82(3):122-6. PubMed ID: 11952985
[TBL] [Abstract][Full Text] [Related]
31. Monitoring the efficiency of iron chelation therapy: the potential of nontransferrin-bound iron.
Hider RC; Silva AM; Podinovskaia M; Ma Y
Ann N Y Acad Sci; 2010 Aug; 1202():94-9. PubMed ID: 20712779
[TBL] [Abstract][Full Text] [Related]
32. A fluorescence-based one-step assay for serum non-transferrin-bound iron.
Breuer W; Cabantchik ZI
Anal Biochem; 2001 Dec; 299(2):194-202. PubMed ID: 11730343
[TBL] [Abstract][Full Text] [Related]
33. Intestinal absorption and enterohepatic cycling of biliary iron originating from plasma non-transferrin-bound iron in rats.
Brissot P; Bolder U; Schteingart CD; Arnaud J; Hofmann AF
Hepatology; 1997 Jun; 25(6):1457-61. PubMed ID: 9185768
[TBL] [Abstract][Full Text] [Related]
34. Erratum to "Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron". [FEMS Immunol. Med Microbiol. 37 (2003) 45-51].
von Bonsdorff L; Sahlstedt L; Ebeling F; Ruutu T; Parkkinen J
FEMS Immunol Med Microbiol; 2004 Mar; 40(2):173-80. PubMed ID: 15040393
[TBL] [Abstract][Full Text] [Related]
35. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.
Grosse R; Lund U; Caruso V; Fischer R; Janka GE; Magnano C; Engelhardt R; Dürken M; Nielsen P
Ann N Y Acad Sci; 2005; 1054():429-32. PubMed ID: 16339692
[TBL] [Abstract][Full Text] [Related]
36. Non-transferrin-bound iron and tumor cells.
Anghileri LJ; Thouvenot P
Anticancer Res; 1997; 17(4A):2529-33. PubMed ID: 9252675
[TBL] [Abstract][Full Text] [Related]
37. Catecholamine inotropes as growth factors for Staphylococcus epidermidis and other coagulase-negative staphylococci.
Neal CP; Freestone PP; Maggs AF; Haigh RD; Williams PH; Lyte M
FEMS Microbiol Lett; 2001 Jan; 194(2):163-9. PubMed ID: 11164302
[TBL] [Abstract][Full Text] [Related]
38. Effect of bicarbonate on stability of the gallium-transferrin complex.
Staker BL; Graham MM; Evans ML
J Nucl Med; 1991 Jul; 32(7):1439-41. PubMed ID: 2066803
[TBL] [Abstract][Full Text] [Related]
39. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.
Schrezenmeier H; Walther-Wenke G; Müller TH; Weinauer F; Younis A; Holland-Letz T; Geis G; Asmus J; Bauerfeind U; Burkhart J; Deitenbeck R; Förstemann E; Gebauer W; Höchsmann B; Karakassopoulos A; Liebscher UM; Sänger W; Schmidt M; Schunter F; Sireis W; Seifried E
Transfusion; 2007 Apr; 47(4):644-52. PubMed ID: 17381623
[TBL] [Abstract][Full Text] [Related]
40. Influence of dietary catechols on the growth of enteropathogenic bacteria.
Freestone PP; Walton NJ; Haigh RD; Lyte M
Int J Food Microbiol; 2007 Nov; 119(3):159-69. PubMed ID: 17850907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
